Mark McClellanMCCLELLAN TO JOIN BOARD OF DIRECTORS Mark B. McClellan, M.D., Ph.D., Senior Fellow in Economic Studies and Director of the Initiative on Value and Innovation in Health Care, Brooking Institution to join the Johnson & Johnson Board of Directors. Dr. McClellan served as commissioner of the United States Food and Drug Administration from 2002 to 2004.

Johnson & Johnson has announced that Mark B. McClellan, M.D., Ph.D., Senior Fellow in Economic Studies, and Director of the Initiative on Value and Innovation in Health Care, Brookings Institution, has been appointed to its Board of Directors.

Dr. McClellan will formally join the Board on October 15, 2013 and will serve on the Regulatory, Compliance & Government Affairs Committee and the Science, Technology & Sustainability Committee of the Board.

As former commissioner of the U.S. Food and Drug Administration (FDA) from 2002 to 2004, and as the former administrator of the Centers for Medicare & Medicaid Services (CMS) for the U.S. Department of Health and Human Services from 2004 to 2006, Dr. McClellan has more than two decades of public service and academic research experience. From 2001 to 2002, he served as a member of the President’s Council of Economic Advisers and senior director health care policy at the White House. During President William J. Clinton’s administration,
Dr. McClellan held the position of deputy assistant secretary of the Treasury for economic policy.

“Dr. McClellan has a distinguished record in the public sector as well as a deep understanding and vision for the future of health care,” said Alex Gorsky, Chairman and Chief Executive Officer of Johnson & Johnson. “Mark shares our aspiration to help people live longer, healthier and happier lives, and personally is committed to improving health care across the globe. He will be a valued leader on our Board.”

While at FDA, Dr. McClellan implemented the Critical Path Initiative, regulatory reforms to modernize pharmaceutical manufacturing, and new initiatives on food safety and security. Dr. McClellan has also led the development of performance-based health care payment reforms, insurance coverage reforms, and a range of public-private initiatives to help improve care and lower costs. 

Dr. McClellan previously served as an associate professor of economics and medicine with tenure at Stanford University, where he also directed the Program on Health Outcomes Research. Among other well-known health organizations in which he holds positions, he is the Chair of the Clinician Measure Applications Partnership for the National Quality Forum. Dr. McClellan has received the Kenneth J. Arrow Award twice for Outstanding Research in Health Economics.

A 1985 graduate of the University of Texas at Austin, Dr. McClellan earned his MD degree at the Harvard University–Massachusetts Institute of Technology (MIT) Division of Health Science and Technology, and his Master’s in Public Administration (MPA) at the Kennedy School of Government at Harvard. He earned his Ph.D. in Economics at Massachusetts Institute of Technology (MIT) and completed his residency in internal medicine at Brigham and Women’s Hospital in Boston.